boris cherny goes on a podcast every three months and says something like “i’ve stopped breathing now i just wrote a breath.md” and the next day everyone in sf stops breathing
@KrisPatel99@RagingVentures "And mobile is offsetting on the customer relationship side."
This is true but are they not cannibalizing themselves to do this at lower margin and keep them with a package. As well as 4 other players trying to do this and compete on price
it was cute when we were still at the point where youd have some doctor friend text u "what's up with this Nvidia thing" but now its 3yrs later and that friend will text you "000660.KS (에스케이하이닉스 주식회사) is on an MSD P/E with analysts still mis-modeling pricing torque"
I read Goldman Sachs’ AI report, and I was genuinely impressed.
The core insight is as follows:
Agentic AI could turn AI from a capex-heavy cost burden into a business where usage growth drives margin expansion. As token costs fall, more complex agents become economically viable. These agents then consume far more tokens through longer context windows, repeated reasoning loops, validation, tool use, and always-on background monitoring.
This increase in token usage improves infrastructure utilization, strengthens unit economics, and gives hyperscalers and model providers more room to reinvest in model quality, distribution, and capacity.
In other words, the bull case for AI capex is not simply that usage will grow. It is that this usage growth can increasingly flow through at attractive incremental margins. Goldman Sachs argues that this margin inflection is beginning to appear from 2026 onward.
$IQV & $ICLR
CRO’s seem unwarranted in the AI fear de-rate bucket.
Names up after IQV’s Q1 call but still feels cheap.
“Looking forward, large pharma clients tell us they plan to increase the number of molecules in their pipeline because they are using AI to identify more targets, most of which is at the discovery stage. That will increase the number of trials and the number of assets pursued, which in turn increases demand for CRO services, not the opposite.”
AI labs are paying hundreds of thousands of dollars to buy email, Slack and Jira threads from dead startups as feedstock for ‘reinforcement learning gyms,’ which specialize in using defunct company data to build simulated work environments https://t.co/QuCk36wAPY
$SEER
So new Board member Isaac Ro
- Was a VP at Goldman 2010-2019.
- Left and has since driven the sale of multiple life sciences/Biotech businesses for a few $ B's
- Partner at BioTech PE firm
AND his SEER grants accelerate immediately in a CIC.
Anyone looked at this?